Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
ProteinSimple
company
About
ProteinSimple is part of the Protein Platforms division of Bio-Techne (NASDAQ: TECH).
- 101 - 250
Highlights
Details
- Last Funding Type
- Series F
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2001
- Number Of Employee
- 101 - 250
- Operating Status
- Active
ProteinSimple is part of the Protein Platforms division of Bio-Techne (NASDAQ: TECH). They rethinking protein tools and helping thousands of researchers around the world resolve their protein analysis problems so they can reveal new insight into proteins and their role in disease. Their wide-ranging portfolio of tools includes everything from immunoassay systems that quantify protein expression to systems that probe the structure and purity of protein-based therapeutics.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20M
ProteinSimple has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
Oct 14, 2010 from a Series F round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 14, 2010 | Series F | $20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ProteinSimple is funded by 1 investors.
Lansing Brown Investments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series F |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
